A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD

NCT06533553 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Dexpramipexole Dihydrochloride

Sponsor

Areteia Therapeutics